• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Enobia Pharma

edit

Enobia develops therapies to treat serious genetic bone disorders for which there are no approved treatments.

Milestones

edit

• 
  Enobia Pharma received $40M in Unattributed funding. (8/8/11)
  Posted 8/10/11 at 7:28pm via enobia.com
• 
  Enobia Pharma received $15.6M in Series C funding. (1/18/05)
  Posted 7/2/10 at 5:08am
• 
  Enobia Pharma received $37.6M (C$40.1M) in Series B funding. (8/1/07)
  Posted 9/24/09 at 2:33pm via enobia.com
• 
  Enobia Pharma received $50M in Series C funding. (8/10/09)
  Posted 9/24/09 at 2:33pm via enobia.com
• 
  Enobia Pharma was acquired by Alexion Pharmaceuticals. (12/29/11)
  Posted 12/29/11 at 7:47pm via yahoo.com

Videos

Screenshots

edit

Sources

1. Alexion Pharmaceuticals to Acquire Enobia Pharma Corp. (finance.yahoo.com) [edit]
2. Cap Funding Report [edit]
3. enobia.com [edit]
4. Enobia Raises US$50M from Current Investors in Series C Financing (enobia.com) [edit]
5. Enobia Pharma Raises US $40 million (enobia.com) [edit]